×
Choose Speciality

EXPLORE!

LOGIN

By signing up or signing in to eMediNexus, you consent to eMediNexus collecting and using your personal data in accordance with our Privacy Policy. We are committed to safeguarding your information and ensuring the highest standards of data protection. Your trust and privacy are of utmost importance to us.

Renin-angiotensin system inhibition in advanced chronic kidney disease

  785 Views

eMediNexus    30 January 2023

 

This investigation suggests that discontinuing RAS inhibitors does not cause significant between-group discrepancies in the long-term rate of decrease in the eGFR among patients with advanced and progressive chronic kidney disease.

 

Reference- Bhandari S, Mehta S, Khwaja A, et al. Renin–Angiotensin System Inhibition in Advanced Chronic Kidney Disease. New England Journal of Medicine. 2022;387(22):2021-2032. https://www.nejm.org/doi/full/10.1056/NEJMoa2210639

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.